Bleeding News and Research

RSS

11th World Stroke Congress examines high stroke impact in low- and middle-income countries

11th World Stroke Congress brings together leading international stroke experts and an unparalleled scientific program covering epidemiology, prevention, acute care, recovery and rehabilitation in 100s of sessions and oral posters.

22 Oct 2018

Incidence of stroke has risen steadily among marijuana users, show studies

11th World Stroke Congress brings together leading international stroke experts and an unparalleled scientific program covering epidemiology, prevention, acute care, rehabilitation and recovery in 100s of sessions and oral posters.

19 Oct 2018

New blood test could spare cancer patients from unnecessary chemotherapy

Cancer patients could be spared unnecessary chemotherapy - and its side effects - by a new blood test that is in clinical trials at more than 40 hospitals in Australia and New Zealand.

17 Oct 2018

Researchers develop fibrin-targeting immunotherapy to protect against neurodegeneration

Normally, the blood protein fibrin does not enter the brain. But in several neurological disorders, the blood-brain barrier--which keeps large molecules in the blood from entering the brain--becomes abnormally permeable, allowing fibrin to leak into the brain and trigger inflammation.

16 Oct 2018

A new vaccine shows promise in protecting people from rabies, Lassa fever

A novel vaccine designed to protect people from both Lassa fever and rabies showed promise in preclinical testing, according to new research published in Nature Communications.

12 Oct 2018

Scientists uncover how proteins meet on the cell membrane

Scripps Research scientists have uncovered the workings of a critical process in cell survival. Their study, published recently in the Proceedings of the National Academy of Sciences, is the first to show exactly how a protein called talin activates another critical protein, called integrin, to do its job on the cell membrane.

11 Oct 2018

Premature babies with low levels of blood platelets have increased risk of blindness

Premature babies with low levels of platelets (thrombocytes) in their blood run a greatly increased risk of being afflicted with a severe variation of retinopathy of prematurity, an eye disease that can cause blindness, according to a study from Sweden and US published in the journal JCI Insight.

11 Oct 2018

Inflammatory proteins in the colon increase in parallel with increasing weight, study shows

Studies in mice have demonstrated that obesity-induced inflammation contributes to the risk of colorectal cancer, but evidence in humans has been scarce.

11 Oct 2018

King's College researchers awarded £2.3 million for new trial to treat liver disease

Dr Mark McPhail from the Department of Inflammation Biology, School of Immunology & Microbial Sciences and Dr Vishal Patel from the Institute of Liver Studies at King's College Hospital have been awarded £2.3 million by the National Institute of Health Research Health Technology Assessment to lead a new UK wide multi-centre trial to treat liver disease.

9 Oct 2018

Study finds suboptimal antithrombotic care in AFib patients with cancer history

Atrial fibrillation patients with a history of cancer are less likely to see a cardiologist or fill anticoagulant prescriptions compared with AFib patients who never had cancer, according to a study in the Journal of the American College of Cardiology.

8 Oct 2018

Leadiant Biosciences announces FDA approval of Revcovi for treating pediatric, adult ADA-SCID patients

Leadiant Biosciences, Inc. today announced that the Food and Drug Administration has granted approval to Revcovi (elapegademase-lvlr) injection in the U.S. Revcovi is a new enzyme replacement therapy for the treatment of adenosine deaminase severe combined immune deficiency in pediatric and adult patients.

7 Oct 2018

FDA approves HEMLIBRA for treatment of hemophilia A

Chugai Pharmaceutical Co., Ltd. announced today that the U.S. Food and Drug Administration (FDA) has approved HEMLIBRA (US generic name: emicizumab-kxwh), a treatment for hemophilia A created by Chugai, for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adults and children, ages newborn and older, with hemophilia A without factor VIII inhibitors, administered once weekly, every two weeks, or every four weeks.

5 Oct 2018

VA adding opioid antidote to defibrillator cabinets for quicker overdose response

It took more than 10 minutes for paramedics to arrive after a housekeeper found a man collapsed on the floor of a bathroom in a Boston Veteran Affairs building.

3 Oct 2018

Infants face high thrombosis risk

Russian scientists have carried out tests to compare the process of blood coagulation in adults and newborns and discovered that the latter face an increased risk of thrombosis.

1 Oct 2018

TransEnterix’s Senhance Ultrasonic Instrument System receives CE Mark approval

TransEnterix, Inc., a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced that the Company received CE Mark approval for its Senhance Ultrasonic Instrument System.

1 Oct 2018

Chiropractic treatment could lead to vision problems

For those in the habit of getting their neck adjusted by a chiropractor, the University of Michigan Kellogg Eye Center has interesting information to know about: High velocity neck manipulation has been shown to result in stress on the eye and lead to spotty vision.

1 Oct 2018

FDA approves first intravenous treatment for metastatic cutaneous squamous cell carcinoma

The U.S. Food and Drug Administration today approved Libtayo (cemiplimab-rwlc) injection for intravenous use for the treatment of patients with metastatic cutaneous squamous cell carcinoma or locally advanced CSCC who are not candidates for curative surgery or curative radiation.

28 Sep 2018

Bleeding News and Research

11th World Stroke Congress examines high stroke impact in low- and middle-income countries

Incidence of stroke has risen steadily among marijuana users, show studies

New blood test could spare cancer patients from unnecessary chemotherapy

Researchers develop fibrin-targeting immunotherapy to protect against neurodegeneration

A new vaccine shows promise in protecting people from rabies, Lassa fever

Scientists uncover how proteins meet on the cell membrane

Premature babies with low levels of blood platelets have increased risk of blindness

Inflammatory proteins in the colon increase in parallel with increasing weight, study shows

King's College researchers awarded £2.3 million for new trial to treat liver disease

Study finds suboptimal antithrombotic care in AFib patients with cancer history

Leadiant Biosciences announces FDA approval of Revcovi for treating pediatric, adult ADA-SCID patients

FDA approves HEMLIBRA for treatment of hemophilia A

VA adding opioid antidote to defibrillator cabinets for quicker overdose response

Infants face high thrombosis risk

TransEnterix’s Senhance Ultrasonic Instrument System receives CE Mark approval

Chiropractic treatment could lead to vision problems

FDA approves first intravenous treatment for metastatic cutaneous squamous cell carcinoma

Scientists discover most important target of MRSA bacterial toxin and ways to neutralize it

UCI study finds new cause of cerebral microbleeds

Recurrence risk of VTE appears similar for patients with cancer and those with unprovoked VTE

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News